Produkty 2122245-63-8

CAS 2122245-63-8 występuje w naszej ofercie pod nazwami: Abiraterone Acetate–d4, Abiraterone acetate-d4. Oferty producentów: GLPBio, MedChemExpress. Dostępne opakowania: 1mg, 10mg, 5mg, 500μg, 1 mg.

Abiraterone Acetate–d4
GLPBio
  • opakowanie: 1mg, 10mg, 5mg, 500μg
  • Warianty: 4
od 1013,60
Zobacz produkt
Abiraterone acetate-d4
MedChemExpress
  • opakowanie: 1 mg
  • Warianty: 1
od 3189,68
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate (CAS 2122245-63-8) to związek chemiczny o wzorze sumarycznym C26H33NO2 i masie molowej 395.6 g/mol. Nazwa systematyczna IUPAC: [(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate. InChIKey: UVIQSJCZCSLXRZ-IYDYMXCUSA-N.

Dane identyfikacyjne
Wzór sumarycznyC26H33NO2
Masa molowa395.6 g/mol
Nazwa IUPAC[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(2,4,5,6-tetradeuterio-3-pyridinyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
InChIKeyUVIQSJCZCSLXRZ-IYDYMXCUSA-N
SMILES[2H]C1=C(C(=C(N=C1[2H])[2H])C2=CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)OC(=O)C)C)C)[2H]

Dane obliczone przez PubChem (NCBI)

Synonimy: Abiraterone Acetate-d4, (3ss)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol Acetate-d4 (Ester); CB 7630-d4;
Powiązane formy tego związku
[(3R,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C26H33NO2
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C26H33NO2
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] 2,2,2-trideuterioacetate C26H33NO2
Izomery (ten sam wzór sumaryczny)
1-adamantyl 1-(cyclohexylmethyl)indole-3-carboxylate C26H33NO2
(2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide C26H33NO2
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-2-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C26H33NO2
[(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-4-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C26H33NO2
(2Z,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide C26H33NO2
(2E,4E,6E,8E)-3,7-dimethyl-N-(2,3,5,6-tetradeuterio-4-hydroxyphenyl)-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide C26H33NO2